MedicNest.euLive Grid

bt_bb_section_bottom_section_coverage_image

Type: Cluster Project page: Access page Country: France Synopsis: The cluster brings together industrial players, large groups, SMEs and start-ups, research laboratories, university hospitals, universities and schools in the complete, relevant and competitive value chain of biomedicine, from target discovery to clinical evaluation. Building on a strong territorial presence, with a strong growth dynamic and...

Type: Cluster Project page: Access page Country: France Synopsis: Lyonbiopole is the health competitiveness cluster of the Auvergne-Rhône-Alpes region. We bring together, advise and work with more than 275 members – companies, academics and hospitals – with their plans to innovate, grow, expand internationally and host new projects. We support these biotech, medtech and digital...

FranceGENOPOLE

January 27, 2023by pcdata0

Type: Cluster Project page: Access page Country: France Synopsis: Genopole shapes and vivifies a research hub for genomics and life sciences, energizes the growth of biotechnologies by creating, accompanying and welcoming innovative businesses, strengthens a life sciences academic center, and organizes lively scientific events at the biocluster.

Dates: 01/01/2021 31/12/2025 Topic: Tool Procedures Project type: Preclinic Project target: Cancer Financing: H2020-EU.3.1. – SOCIETAL CHALLENGES – Health; demographic change and well-being H2020-EU.3.1.7. – Innovative Medicines Initiative 2 (IMI2) Other Participating agents: UNIVERSITAETSKLINIKUM WUERZBURG – KLINIKUM DER BAYERISCHEN JULIUS-MAXIMILIANS-UNIVERSITAT Keywords: Countries: Germany; UK; Italy; France; Austria; Spain; Belgium; Luxembourg; Switzerland Project page: Access page...

Dates: 01/10/2020 31/12/2024 Topic: Tool AI/Big data Project type: Preclinic Clinic Theranostic Project target: Cervical Cancer Financing: H2020-EU.3.1. – SOCIETAL CHALLENGES – Health; demographic change and well-being H2020-EU.3.1.2. – Preventing disease Participating agents: STICHTING VUMC Keywords: screening; cervical cancer; tumour; HPV; cytology; DNA; e-health; vaccine; clinical trial Countries: Netherlands; Sweden; France; Finland; Spain; Belgium; Slovenia;...

Dates: 01/07/2022 30/06/2027 Topic: Biomarkers identification Project type: Preclinic Project target: Liver cancer Other Financing: H2020-EU.1.1. – EXCELLENT SCIENCE – European Research Council (ERC) Participating agents: INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE THE UNIVERSITY OF TEXAS SYSTEM Keywords: liver cancer; oncology; tumour; cihrosis; biomarker; hepatology; HCC; claudin-1; Countries: France; USA Project...

Dates: 01/03/2019 28/02/2026 Topic: Biomarkers identification Project type: Preclinic Project target: Other Financing: H2020-EU.1.1. – EXCELLENT SCIENCE – European Research Council (ERC) Participating agents: INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE Keywords: aging; neurobiology; glial cell; obesity; homeostasis; biomarker; tanycyte Countries: France; Spain; Germany Project page: Access page  

Dates: 01/09/2021 31/08/2025 Topic: Tool Project type: Preclinic Project target: Other Financing: H2020-EU.1.2. – EXCELLENT SCIENCE – Future and Emerging Technologies (FET) H2020-EU.1.2.1. – FET Open Participating agents: CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE CNRS Keywords: protein; biosensor; cell biology; biophysic; LEDIs; electrodynamic interactions Countries: France; Switzerland; Germany; Nehterlands Project page: Access page  

Dates: 01/01/2020 31/12/2025 Topic: Biomarkers identification AI/Big Data DRUG Project type: Clinic Project target: Infectious Disease Financing: H2020-EU.3.1. – SOCIETAL CHALLENGES – Health; demographic change and well-being H2020-EU.3.1.7. – Innovative Medicines Initiative 2 (IMI2) Other Participating agents: UNIVERSIDAD CARLOS III DE MADRID Keywords: drug discovery; AI; diabetes; tuberculosis; oral drug; infectius disease; clinical trial Countries:...

Dates: 01/01/2019 31/03/2025 Topic: Biomarkers identification Tool AI/Big Data Project type: Preclinic Clinic Project target: Other Financing: H2020-EU.3.1. – SOCIETAL CHALLENGES – Health; demographic change and well-being H2020-EU.3.1.2. – Preventing disease Participating agents: EUROPEAN FOUNDATION FOR THE STUDY OF CHRONIC LIVER FAILURE (EF-CLIF) Keywords: liver cihrrosis; biomarker; clinical trial; ACLF; acute-on-chronic liver failure; OMICs; hepatology;...